Phase III Trial of Lapatinib: Discontinued due to Inferior Efficacy

Author:  

Publisher: Adis International

ISSN: 1178-2595

Source: Pharmaceutical Medicine, Vol.26, Iss.5, 2012-10, pp. : 321-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract